The Danger of ‘Invisible’ Biolabs Across the U.S.
September 7, 2023
(TIME) – To summarize: bio labs in the U.S. fall through the cracks of government oversight if they are privately operated (i.e., not academic or government), do not receive funding from the government, and are not working with select agents. These “invisible” labs have much more leeway to work with pathogens that are not select agents but could still cause outbreaks, severe illness, and death—a category that includes some of the ones that the Reedley lab acquired. A forthcoming report by Gryphon Scientific, the biosafety and public health consultancy where one of us works, estimates that about ¼ of human pathogen research activities in the U.S. are performed by labs inside of private organizations, and about ¼ of those private organizations are “invisible.” (Read More)